Clinical Trials on 免疫检查点抑制剂 in United Kingdom
总计24637个结果
-
Imperial College London完全的
-
Novartis Pharmaceuticals终止c-MET抑制剂; PI3K 抑制剂、PTEN 突变、PTEN 纯合缺失或 PTEN 阴性。通过 IHC,c-Met Ampli。通过 FISH、INC280、BKM120、Buparlisib;复发性GBM西班牙, 瑞士, 德国, 美国, 荷兰
-
Imperial College LondonJP Moulton Charitable Foundation; Sociedad Española de Alergología e Inmunología; Sociedad Española...完全的
-
Cambridge University Hospitals NHS Foundation TrustImperial College London; University of Manchester未知
-
Loughborough UniversityKarolinska Institutet; University of Nottingham; University of Copenhagen; Duke University; Medical... 和其他合作者完全的
-
Queen Mary University of LondonBarts & The London NHS Trust; Papworth Hospital NHS Foundation Trust招聘中
-
Royal Devon and Exeter NHS Foundation TrustUniversity of Exeter未知
-
Guy's and St Thomas' NHS Foundation Trust未知
-
St George's, University of LondonPublic Health England招聘中
-
King's College LondonDiabetes UK; Guy's and St Thomas' Foundation NHS Trust完全的
-
NHS Greater Glasgow and ClydeWyeth is now a wholly owned subsidiary of Pfizer; University of Glasgow; Chief Scientist Office... 和其他合作者未知
-
Medtronic Bakken Research CenterMedtronic完全的
-
Chiesi Farmaceutici S.p.A.完全的
-
University of ManchesterMedical Research Council; JP Moulton Charitable Foundation完全的
-
St George's, University of LondonUniversity Hospital Southampton NHS Foundation Trust; St George's University Hospitals NHS Foundation...招聘中
-
Queen Mary University of LondonUniversity of Nottingham; University of Edinburgh; University of Cambridge; National Institute for... 和其他合作者招聘中
-
Western Health and Social Care TrustUniversity of Ulster撤销
-
Sheffield Children's NHS Foundation Trust完全的
-
Pipeline Therapeutics, Inc.完全的
-
University of NottinghamSwansea University; Multiple Sclerosis Society UK完全的
-
University College, LondonUniversity College London Hospitals未知